GENELUX Corp

For the period ended Dec 31, 2023. Filed Mar 29, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 29, 2024

GNLX$1.95-5.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets at December 31, 2023 and 2022

Balance Sheets

(In thousands, except for share amounts and par value data)

	December 31,
	2023	2022
ASSETS
Current Assets
Cash and cash equivalents	$9,418	$397
Short-term investments	13,773	-
Prepaid expenses and other current assets	1,012	1,495
Total Current Assets	24,203	1,892
Property and equipment, net	1,170	644
Right of use assets	2,428	1,335
Deferred offering costs	-	1,568
Other assets	92	92
Total Other Assets	3,690	3,639
TOTAL ASSETS	$27,893	$5,531
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
Current Liabilities
Accounts payable and accrued expenses	$3,784	$6,775
Accrued payroll and payroll taxes	2,117	2,852
Accrued interest payable	-	1,178
Accrued interest payable - director and shareholders	-	3,817
Deferred revenue	-	170
Warrant liabilities	-	169
Lease liability, current portion	653	266
Notes payable - shareholders, net of debt discount of $108 in 2022	-	992
Convertible notes payable - shareholders, current portion	-	15,407
Total Current Liabilities	6,554	31,626
Long-term Liabilities
Lease liability, long-term portion	1,866	1,164
Convertible notes payable, net of debt discount of $541 in 2022	-	8,524
Total Long-term Liabilities	1,866	9,688
Total Liabilities	8,420	41,314
Shareholders’ Equity (Deficit)
Preferred stock, Series A through K, par value $0.001, 10,000,000 shares authorized as of 12/31/2023 and 29,927,994 authorized as of 12/31/2022; no shares and 22,094,889 shares issued and outstanding, respectively;	-	22
Common stock, par value $0.001, 200,000,000 shares authorized; 26,788,986 and 9,126,726 shares issued and outstanding, respectively	27	9
Treasury stock, 433,333 shares, at cost	(433)	(433)
Additional paid-in capital	241,389	154,401
Accumulated other comprehensive income	14	2
Accumulated deficit	(221,524)	(189,784)
Total Shareholders’ Equity (Deficit)	19,473	(35,783)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)	$27,893	$5,531

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.